MedicineNephrologyOncologyBone MetabolismCalcium HomeostasisMineral MetabolismBone DisordersBone Metabolism DisordersBone TumorsDisorders Of Calcium MetabolismDisorders Of Phosphate MetabolismMetabolic Bone DiseaseBone Pain In CancerClinical Laboratory EvaluationEndocrine Paraneoplastic SyndromesLaboratory Test EvaluationMineral Metabolism DisordersPhosphate Homeostasis DisordersRenal Phosphate WastingTumor-induced Osteomalacia
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic form of renal phosphate wasting that results in severe hypophosphatemia, a defect in vitamin D metabolism, and osteomalacia. This debilitating disorder is illustrated by the clinical presentation of a 55-year-old woman with progressive fatigue, weakness, and muscle and bone pain with fractures. After a protracted clinical course and extensive laboratory evaluation, tumor-induced osteomalacia was identified as the basis of her clinical presentation. In this article, the distinctive clinical characteristics of this syndrome, the advances in diagnosis of TIO, and new insights into the pathophysiology of this disorder are discussed.
93
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa, Yuji Yamazaki, Takashi Shimada et al. · Nature · 2006 · 1.8K citations
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
Kenneth E. White, W. Evans, Jeffery L.H. O'Riordan et al. · Nature Genetics · 2000 · 1.5K citations
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Hiroshi Kurosu, Yasushi Ogawa, Masayoshi Miyoshi et al. · Journal of Biological Chemistry · 2006 · 1.4K citations · Full text